As one of the world‘s leading technology providers to the life sciences and biopharma industries, Sartorius is actively shaping dynamic, innovative and high-growth markets. To drive the creation of new innovative solutions, Sartorius has formed a global Corporate Research initiative. This group will discover new trends and cutting edge opportunities for rapid conversion towards next generation technology solutions. This challenging endeavor will include dynamic innovation opportunities with research institutes and start up technology companies around the world.
We are seeking a highly motivated scientist to contribute to towards developing novel technologies and evaluation of cutting-edge research projects. Examples of projects could include improving Stem/T Cell culture, and drug screening using spheroids/organoids through employing novel microfluidic approaches. This research will include the translation of these miniaturization approaches for prediction / simulation of larger scale bioprocessing. By working at the interface of cell engineering and bioprocessing, the candidate will work as part of a multidisciplinary collaborative team of molecular biologists, data scientists, sensoric experts, and bioprocess / automation engineers.
What you will accomplish together with us:
- Carry out research into new therapies, such as cell and gene therapy, at the interface of cell engineering into bioprocessing production.
- Execute the translation of new biological molecular tools into bioprocessing application for improved cell performance in combination with microfluidic & automation approaches.
- Identify and establish collaborations with world leading academics and startup companies for cutting edge technology concepts
- Guide and provide practical support for completion of proof of concept experimental evaluations
- Drive and support potential prototype technology design
- Responsible for the technology transfer of promising technology candidates to the Technology Development team.
What will convince us:
- PhD in molecular biology, cellular biology, bioengineering, biomedical or chemical engineering or closely related field with experience with biological cellular systems.
- Have established both a foundationally theoretical and practical competency that is internationally recognized through publications and presentations.
- Hands on experience on mammalian cell culture and various bioassays.
- A practical competency in cell or gene therapy technologies is preferred.
- A desire for miniaturization and automation for developing the next generation personalized automated workflows.
- A willingness to learn from other disciplines and industry sectors.
- Develop skills to drive & influence multidisciplinary teams such as data scientists and bioprocess engineers
- Ability to prioritize tasks and balance individual technical contribution with coordination of fast paced research activities across multiple sites, organizations, and disciplines
- Ability to work smoothly in a team and independently
- Requires domestic & some international travel
- Identification with our core values: Sustainability, Openness, Enjoyment
What we offer
Sartorius’ ambition is to simplify progress in the bio-pharmaceutical industry to help translate scientific findings into new therapeutics faster and more efficiently. Nearly 10,000 employees at more than 60 sites are working together on achieving our goal: Better health for more people. And together, we have grown strongly over the past years. Enjoy the advantages of working with a global player:
- Opportunity for international career development:
- a global network offering seminars and training sessions, expert and manager career paths
- Open and highly collaborative culture: mutual support within teams and working as equals, team spirit and international collaboration
- Intelligent working environment: working in smart buildings with the latest technology and equipment
- Ambitious goals: Sartorius plans to double its sales revenue approximately every five years and expects to grow its global team to approximately 15,000 people in 2025.